Carmen Ortiz Mellet Selected Research

Conjoined Twins (Siamese Twins)

7/2019

Trehalose-based Siamese twin amphiphiles with tunable self-assembling, DNA nanocomplexing and gene delivery properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carmen Ortiz Mellet Research Topics

Disease

13	Gaucher Disease (Gaucher's Disease) 01/2017 - 11/2009
4	Infections 10/2022 - 02/2010
4	Inflammation (Inflammations) 07/2022 - 05/2010
4	Neoplasms (Cancer) 12/2021 - 02/2010
3	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2010
2	Glioblastoma (Glioblastoma Multiforme) 12/2020 - 01/2017
2	GM1 Gangliosidosis (Gangliosidosis GM1) 05/2014 - 03/2013
2	Mucopolysaccharidosis IV (Morquio Syndrome) 05/2014 - 03/2013
1	Asthma (Bronchial Asthma) 01/2023
1	Tay-Sachs Disease 12/2022
1	Leishmaniasis 12/2021
1	Gliosis 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019
1	Rare Diseases (Rare Disease) 07/2019
1	Conjoined Twins (Siamese Twins) 07/2019
1	Mannosidase Deficiency Diseases (Mannosidosis) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Fabry Disease (Fabry's Disease) 09/2015
1	Neurologic Manifestations (Neurological Manifestations) 06/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2015
1	Pathologic Processes 01/2015
1	Human Influenza (Influenza) 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 11/2014
1	Adenocarcinoma 11/2013
1	Teratoma (Teratoid Tumor) 02/2013
1	Edema (Dropsy) 01/2011

Drug/Important Bio-Agent (IBA)

9	Glucosylceramidase (Glucocerebrosidase)IBA 01/2017 - 11/2009
6	GlucosidasesIBA 12/2014 - 11/2010
5	EnzymesIBA 12/2022 - 06/2011
5	GlycolipidsIBA 07/2022 - 11/2014
4	CyclodextrinsIBA 12/2020 - 04/2014
4	AcidsIBA 04/2014 - 11/2010
3	GalactosidasesIBA 09/2015 - 03/2013
2	AntigensIBA 01/2020 - 01/2011
2	Surface-Active Agents (Surfactants)IBA 07/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 11/2013
2	GlycosidesIBA 01/2015 - 08/2012
2	OligosaccharidesIBA 01/2015 - 02/2010
2	Glucosylceramides (Glucocerebrosides)IBA 04/2014 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 06/2011 - 11/2009
2	FructoseIBA 05/2010 - 02/2010
1	Serine (L-Serine)FDA Link 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	OvalbuminIBA 01/2023
1	Hexosaminidase A (Hex A)IBA 12/2022
1	Hexosaminidases (Hexosaminidase)IBA 12/2022
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2022
1	Anti-Infective Agents (Microbicides)IBA 10/2022
1	InflammasomesIBA 07/2022
1	LipidsIBA 12/2021
1	SulfurIBA 12/2021
1	SeleniumIBA 12/2021
1	NitrogenIBA 12/2021
1	sulfoxideIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 12/2020
1	AntibodiesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	GlycopeptidesIBA 01/2020
1	Tn antigenIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Galactosylceramides (Galactocerebrosides)IBA 11/2019
1	KRN 7000 (KRN7000)IBA 11/2019
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 07/2019
1	DisaccharidesIBA 07/2019
1	TrehaloseIBA 07/2019
1	1- dodecylsulfonyl- 5N,6O- oxomethylidenenojirimycinIBA 05/2019
1	LipopolysaccharidesIBA 05/2019
1	MannosidesIBA 05/2019
1	Interleukin-6 (Interleukin 6)IBA 05/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2019
1	Toll-Like Receptor 4IBA 05/2019
1	alpha-Mannosidase (LAMAN)IBA 01/2019
1	MannosidasesIBA 01/2019
1	NucleotidesIBA 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Calixarenes (Calixarene)IBA 01/2017
1	CholesterolIBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015
1	coenzyme Q10 (CoQ10)IBA 06/2015
1	Ambroxol (Mucosolvan)IBA 01/2015
1	Mannose (D-Mannose)IBA 01/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2013
1	migalastatIBA 03/2013
1	LigandsIBA 03/2013
1	5N,6S- (N'- butyliminomethylidene)- 6- thio- 1- deoxygalactonojirimycinIBA 03/2013
1	SphingolipidsIBA 02/2013
1	5- N,6- O- (N''- octyliminomethylidene)nojirimycinIBA 06/2011
1	nojirimycinIBA 06/2011
1	anthrax toxin (anthrax lethal factor)IBA 01/2011
1	castanospermineIBA 08/2010
1	alpha-Glucosidases (Acid Maltase)IBA 08/2010
1	Glycoproteins (Glycoprotein)IBA 08/2010
1	Sucrose (Saccharose)IBA 05/2010

Therapy/Procedure

4	Therapeutics 11/2019 - 06/2011
1	Enzyme Replacement Therapy 06/2015
1	Oral Administration 03/2013